Islam Mohammad Sazzadul, Tatsumi Yasutoshi, Takano Ryo, Yokochi Tomoki, Akter Jesmin, Ozaki Toshinori, Nakamura Yohko, Ohira Miki, Nakagawara Akira
Laboratory of Innovative Cancer Therapeutics, Japan; Department of Molecular Biology and Oncology, Chiba University Graduate School of Medicine, Chiba, Japan.
Laboratory of Innovative Cancer Therapeutics, Japan; Laboratory of Oncogenomics, Japan.
Biochem Biophys Res Commun. 2016 Sep 9;478(1):81-86. doi: 10.1016/j.bbrc.2016.07.089. Epub 2016 Jul 22.
BCH motif-containing molecule at the carboxyl terminal region 1 (BMCC1)/PRUNE2 is highly expressed in patients with favorable neuroblastoma (NB), encoding a multifunctional scaffold protein that modulates several signaling networks including RhoA and AKT pathways. Accumulating evidence suggests that BMCC1 acts as a tumor-suppressor. In this study, we addressed molecular mechanism underlying transcriptional regulation of BMCC1 in NBs. We found that transcription factor E2F1 was recruited to E2F-binding site in the promoter region of BMCC1 gene. Indeed, overexpression of E2F1 resulted in an increase in the expression level of BMCC1 in NB cell lines. On the other hand, knockdown of E2F1 in NB cells yielded down-regulation of BMCC1. Also, we showed that BMCC1 and E2F1 were simultaneously induced at G1 to S phase transition. Therefore, we conclude that E2F1 directly facilitated BMCC1 transcription. Taking together, these results suggest that BMCC1 induced by E2F1 acts as a tumor suppressor through its pro-apoptotic function, resulted in favorable prognosis of NB.
羧基末端区域含BCH基序分子1(BMCC1)/PRUNE2在预后良好的神经母细胞瘤(NB)患者中高表达,编码一种多功能支架蛋白,该蛋白可调节包括RhoA和AKT通路在内的多个信号网络。越来越多的证据表明BMCC1起着肿瘤抑制作用。在本研究中,我们探讨了NB中BMCC1转录调控的分子机制。我们发现转录因子E2F1被招募到BMCC1基因启动子区域的E2F结合位点。事实上,E2F1的过表达导致NB细胞系中BMCC1表达水平增加。另一方面,NB细胞中E2F1的敲低导致BMCC1下调。此外,我们还表明BMCC1和E2F1在G1到S期转换时同时被诱导。因此,我们得出结论,E2F1直接促进BMCC1转录。综上所述,这些结果表明,由E2F1诱导的BMCC1通过其促凋亡功能发挥肿瘤抑制作用,从而导致NB预后良好。